- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Deborah D. Albright, MD
- Assistant Professor of Pediatrics
- Physician Lead for the Pediatric Allergy Immunology Advanced Practice Provider Fellowship
Dr. Albright has worked in the field of Allergy/Immunology for over fifteen years prior to becoming an Assistant Professor of Pediatrics. She received her undergraduate degree from the Pennsylvania State University and her medical degree from the University of Pittsburgh. She has wide breadth of clinical experience practicing in both the United States Air Force and private practice sectors in addition to her affiliations with several academic institutions throughout her career. Her interests include teaching, quality of care initiatives, food allergy prevention management and aeroallergen and food immunotherapy. She is the primary site investigator at the UPMC Children's Hospital of Pittsburgh for the EPITOPE peanut patch study for children ages 1-3 years. She is also the Allergy/Immunology Physician Lead Liaison for the UPMC Children's Hospital of Pittsburgh Advance Practice Provider Curriculum. She is also the division's physician champion for optimization of use of electronic medicalrecord.
Professional and Scientific Society Memberships
- American Academy of Allergy Asthma & Immunology, 2003-Present
- American College of Allergy, Asthma & Immunology, 2003-Present
Education & Training
- BS, Life Sciences, Pennsylvania State University, 1993
- MD, University of Pittsburgh School of Medicine, 1997
- Internship and Residency in Pediatrics, Wright-Patterson Air Force Base and The Children’s Medical Center of Dayton, 1997-2000
- Fellowship in Allergy/Immunology, Wilford Hall Medical Center, Lackland Air Force Base, 2003-2005
Selected Publications
Albright D. 88th Medical Group Instruction 44-157. Latex Allergy Hospital Operating Instructions, Wright- Patterson Medical Center, Mar 10, 2006
Albright D, Hagan L. Case report: Acute bullous skin reactions after imported fire ant envenomation. Pediatric Asthma, Allergy and Immunology. 2006; 119(1):31-35
Albright D, Jordan-Wagner D, Napoli D, Parker A, Quance-Fitch F, Whisman B, Collins J, Hagan L. Multi-colored Asian Lady Beetle Hypersensitivity: A Case Series. Ann Allergy Asthma Immunol. 2006; 97: 521-527
Albright D, Hagan L. Case report: Bullous scarring reactions after imported fire ant (IFA) envenomation. J Allergy Clin Immunol. 2004; 113(2):S76
Academic and Research Interests
- Peanut oral immunotherapy and epicutaneous immunotherapy
- Macrogol Hypersensitivity
- Asian lady beetle (Harmonia axyridis) Allergy
- Cat Dander Allergy and Immunotherapy
Research Grants
A Double-Blind, Placebo-Controlled Randomized Trial To Study The Viaskin® Milk Efficacy And Safety For Treating IgE-Mediated Cow’s Milk Allergy In Children (Miles Study). Role: Sub-Investigator
Long-term Assessment of Safety and Therapeutic Benefit of Viaskin® Peanut Epicutaneous Treatment in Peanut-Allergic Children: A 6-Month Randomized, Double-Blind, Placebo-Controlled Phase III Study Followed by and Open Label Active Treatment (REALISE). Role: Sub-Investigator
Open-Label Follow-Up Study Of The PEPITES Study to Evaluate The Long-Term Efficacy And Safety Of The Viaskin® Peanut (PEOPLE). Role: Sub-Investigator
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization In Children And Adults (the PALISADE Study)-ARC008. Role: Sub-Investigator
A Double-Blind, Placebo-Controlled, Randomized Phase III Trial To Assess The Safety And Efficacy Of Viaskin® Peanut In Peanut-Allergic Young Children 1-3 Years Of Age (EPITOPE study). Role: Primary Investigator
Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (elapegademase-lvlr). Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy. Role:Sub-Investigator